-
2025-521640-38-00
5
2025-10-16
Focal onset seizures or primary generalized tonic-clonic seizures.
-
2025-520490-38-00
3
2025-10-13
Haemophilia A with or without inhibitors. Proposed indication under de
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2024-517330-18-00
4
2025-10-02
advanced, non resectable or metastatic cholangio- or gallbladder carci
-
2024-517780-24-00
5
2025-09-18
Lung Cancer
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2023-510522-32-00
5
2025-08-29
radiation-induced oral mucositis
-
2024-516412-17-00
5
2025-08-26
Developmental and Epileptic Encephalopathies (DEE)
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2024-514296-17-00
3
2025-08-05
Attention deficit hyperactivity disorder
-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2024-517237-40-00
8
2025-07-03
Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (C
-
2024-519219-32-00
5
2025-06-23
Heart Failure With Reduced Ejection Fraction
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2023-510294-34-00
5
2025-06-12
small lymphocytic lymphoma (SLL)
-
2024-510614-33-00
4
2025-06-10
Ovarian Cancer
-
2023-509680-25-00
6
2025-06-03
Mood disorder (major depressive disorder and bipolar disorder (current
-
2023-509547-27-00
5
2025-05-22
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2024-515395-12-00
4
2025-05-22
Adults with ADHD and moderate to severe depression
-
2024-517422-25-00
5
2025-05-22
Metastatic Castration-resistant Prostate Cancer (mCRPC)